MedPath

Tianjin Medical University Cancer Institute & Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation

Phase 2
Conditions
Non-small Cell Lung Cancer Stage III
Interventions
First Posted Date
2012-09-11
Last Posted Date
2016-10-20
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
94
Registration Number
NCT01683175
Locations
🇨🇳

The affiliated hospital of medical college Qingdao University, Qingdao, China

🇨🇳

Zhejiang Cancer Hospital, Hangzhou, China

🇨🇳

The third affiliated hospital of Harbin Medical Univer, Harbin, China

and more 12 locations

Clinical Application of Breast Blood-oxygen Functional Imaging Technology

Conditions
Breast Diseases
First Posted Date
2012-09-03
Last Posted Date
2015-12-22
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
200
Registration Number
NCT01678170
Locations
🇨🇳

Department of Breast Imaging, Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China

Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy

Phase 2
Conditions
Squamous Cell Lung Cancer
Interventions
First Posted Date
2012-08-08
Last Posted Date
2015-12-22
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
300
Registration Number
NCT01660399
Locations
🇨🇳

Department of Pulmonary Medical Oncology, Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China

Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer

Phase 1
Conditions
Stage IV Gastric Cancer
Interventions
Biological: Antigen-specific cytotoxic T lymphocytes induced by dendritic cells infected by recombinant adeno-associated virus with CEA gene
First Posted Date
2012-07-11
Last Posted Date
2016-03-08
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
30
Registration Number
NCT01637805
Locations
🇨🇳

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes

Conditions
Gastric Cancer
Interventions
Procedure: digestive tract reconstruction
First Posted Date
2012-07-11
Last Posted Date
2016-02-17
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
60
Registration Number
NCT01637350
Locations
🇨🇳

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast Cancer

Conditions
Anthracycline-pretreated Metastatic Breast Cancer
First Posted Date
2012-07-09
Last Posted Date
2015-12-22
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
120
Registration Number
NCT01635465
Locations
🇨🇳

Tianjin Cancer Hospital, Tianjin, Tianjin, China

The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer

Conditions
Breast Cancer
First Posted Date
2012-07-06
Last Posted Date
2015-12-22
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
500
Registration Number
NCT01634984
Locations
🇨🇳

Jin Zhang, Tianjin, China

External Drainage Versus Internal Drainage of Pancreatic Duct With a Stent After Pancreaticoduodenectomy (EDIDPD)

Phase 2
Conditions
Postoperative Fistula
Complications of Surgical and Medical Care: General Terms
Interventions
Procedure: Internal Drainage of Pancreatic Duct after pancreatomy
First Posted Date
2012-07-06
Last Posted Date
2016-02-17
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
120
Registration Number
NCT01634971
Locations
🇨🇳

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Phase 2
Completed
Conditions
Non-small Cell Lung Cancer
Squamous Cell Carcinoma
Interventions
First Posted Date
2012-06-29
Last Posted Date
2019-11-05
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
96
Registration Number
NCT01631357
Locations
🇨🇳

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients

Phase 2
Conditions
Stomach Cancer
Interventions
Drug: XELOX
First Posted Date
2012-06-13
Last Posted Date
2015-12-22
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
100
Registration Number
NCT01618474
Locations
🇨🇳

Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath